<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="./PMC6240620/results/search/disease/results.xml">
  <result pre="with skin-to-skin based transmission mode. HPV annually caused over 500,000" exact="cancer" post="cases including cervical, anogenital and oropharyngeal cancer among others."/>
  <result pre="annually caused over 500,000 cancer cases including cervical, anogenital and" exact="oropharyngeal cancer" post="among others. HPV vaccination has become a public-health concern,"/>
  <result pre="caused over 500,000 cancer cases including cervical, anogenital and oropharyngeal" exact="cancer" post="among others. HPV vaccination has become a public-health concern,"/>
  <result pre="of vaccine development and changes in recommendations for screening of" exact="cancer" post="( 1, 2). HPV is found to be the"/>
  <result pre="mortality and morbidity in the developing countries ( 7). Globally," exact="cervical cancer" post="ranks as the second most common cancer in women"/>
  <result pre="and morbidity in the developing countries ( 7). Globally, cervical" exact="cancer" post="ranks as the second most common cancer in women"/>
  <result pre="7). Globally, cervical cancer ranks as the second most common" exact="cancer" post="in women and is responsible for a significant number"/>
  <result pre="than 100 types of HPV, is an important cause of" exact="cervical cancer" post="( 8, 9). Through the process of immunization along"/>
  <result pre="100 types of HPV, is an important cause of cervical" exact="cancer" post="( 8, 9). Through the process of immunization along"/>
  <result pre="with new diagnostics and applying effective HPV immunization strategies for" exact="cancer" post="control ( 20). Licensed VLP-HPV vaccines should provide long-term"/>
  <result pre="gun, gene gun, and microneedles are being evaluated for HPV" exact="cancer" post="prevention ( 26). Lyophilized HPV pseudovirions have been delivered"/>
  <result pre="types infect women, persistent HPV infections can be established, and" exact="cervical cancer" post="exacerbated ( 26, 35). There is also the involvement"/>
  <result pre="infect women, persistent HPV infections can be established, and cervical" exact="cancer" post="exacerbated ( 26, 35). There is also the involvement"/>
  <result pre="only mild cytological abnormalities; and few HPV infections lead to" exact="cervical cancer." post="HPV can also cause cervical and other cancers such"/>
  <result pre="HPV can also cause cervical and other cancers such as" exact="cancer" post="of the vulva, vagina, penis, or anus. It can"/>
  <result pre="the vulva, vagina, penis, or anus. It can also cause" exact="cancer" post="in the back of the throat, including the base"/>
  <result pre="annually. Therefore, CDC projected that every year roughly 26,000 new" exact="cancer" post="cases occurred as a result of HPV infection, including"/>
  <result pre="cases in females and 8,000 in males. In the U.S.," exact="cervical cancer" post="prevention is based on two approaches: one primary and"/>
  <result pre="in females and 8,000 in males. In the U.S., cervical" exact="cancer" post="prevention is based on two approaches: one primary and"/>
  <result pre="16, 18, 31, 33, 45, 52, and 58) vaccines against" exact="cervical cancer" post="was tested. The bivalent and quadrivalent vaccines reduction in"/>
  <result pre="18, 31, 33, 45, 52, and 58) vaccines against cervical" exact="cancer" post="was tested. The bivalent and quadrivalent vaccines reduction in"/>
  <result pre="shown that immunizations with the HPV-16/18-AS04-adjuvanted vaccine do not promote" exact="autoimmune disease" post="( 48). Chronic local inflammation, alone or as a"/>
  <result pre="awareness of the health risks of HPV infection, such as" exact="cervical cancer" post="and warts that results from education and self-testing is"/>
  <result pre="of the health risks of HPV infection, such as cervical" exact="cancer" post="and warts that results from education and self-testing is"/>
  <result pre="are produced in all HPV-infected cells and are vital for" exact="cancer" post="cells ( 53, 55). Therefore, researchers have focused on"/>
  <result pre="the potential to be used for the development of therapeutic" exact="cancer" post="vaccines ( 85). Sequence alignment studies have detected that"/>
  <result pre="the clearance of established HPV–positive-cancer in vivo ( 90). Recombinant" exact="measles" post="virus (MV) vaccine A vaccine expressing the L1 capsid"/>
  <result pre="HPV-16 that was designed to protect against HPV-16 infection revealed" exact="measles" post="virus for to be a valuable vehicle for the"/>
  <result pre="( 94) for developing a dual vaccine applicable for treating" exact="measles" post="and HPV by using measles vector and inserted genes"/>
  <result pre="dual vaccine applicable for treating measles and HPV by using" exact="measles" post="vector and inserted genes coding for HPV antigens. Vaccinia"/>
  <result pre="human tumors was effectively controlled by immunization with the recombinant" exact="vaccinia virus" post="Ankara (MVA) expressing HPV E2 (MVA-E2). This vaccine showed"/>
  <result pre="previously Xenova or Cantab) is based on a live recombinant" exact="vaccinia virus" post="strain (Wyeth) expressing a modified E6/E7 fusion protein of"/>
  <result pre="led to the most significant development in HPV vaccines and" exact="cervical cancer" post="control ( 121). They expressed recombinant open reading frame"/>
  <result pre="to the most significant development in HPV vaccines and cervical" exact="cancer" post="control ( 121). They expressed recombinant open reading frame"/>
  <result pre="potent live HPV vaccine to simultaneously induce protective immunity against" exact="cervical cancer" post="and typhoid fever ( 125). Live bacteria-based HPV vaccines"/>
  <result pre="live HPV vaccine to simultaneously induce protective immunity against cervical" exact="cancer" post="and typhoid fever ( 125). Live bacteria-based HPV vaccines"/>
  <result pre="vaccine to simultaneously induce protective immunity against cervical cancer and" exact="typhoid fever" post="( 125). Live bacteria-based HPV vaccines such as attenuated"/>
  <result pre="play a significant role in modified HPV-16 E7 and Mycobacterium" exact="tuberculosis" post="Hsp70 fusion DNA vaccine and introduce as candidate therapeutic"/>
  <result pre="may be enhancement of potency of DNA vaccines (used against" exact="cervical cancer" post="induced by HPV) by making DNA or the encoded"/>
  <result pre="be enhancement of potency of DNA vaccines (used against cervical" exact="cancer" post="induced by HPV) by making DNA or the encoded"/>
  <result pre="specific immune effects in women that were protective against advanced" exact="cervical cancer" post="( 181). In another study, a recombinant adenovirus encoding"/>
  <result pre="immune effects in women that were protective against advanced cervical" exact="cancer" post="( 181). In another study, a recombinant adenovirus encoding"/>
  <result pre="linked to DCs induced protective immunity against challenge by TC-1" exact="cancer" post="cells in vivo ( 182). For increasing the efficacy"/>
  <result pre="a dose escalation trial (phase I) has been done in" exact="cervical cancer" post="(stage IIa or Ib) patients ( 184) In case"/>
  <result pre="dose escalation trial (phase I) has been done in cervical" exact="cancer" post="(stage IIa or Ib) patients ( 184) In case"/>
  <result pre="or Ib) patients ( 184) In case of recurrency of" exact="cervical cancer" post="also, phase I clinical trial has been conducted ("/>
  <result pre="Ib) patients ( 184) In case of recurrency of cervical" exact="cancer" post="also, phase I clinical trial has been conducted ("/>
  <result pre="responses. These two vaccines are beneficial in case of recurrent" exact="cervical cancer." post="Both Gardasil and Cervarix have a similar efficiency against"/>
  <result pre="people in the UK with Cervarix prevented females from developing" exact="cervical cancer" post="and protected males from HPV-16 and 18 infections ("/>
  <result pre="in the UK with Cervarix prevented females from developing cervical" exact="cancer" post="and protected males from HPV-16 and 18 infections ("/>
  <result pre="of boys with the 9-valent vaccine reduced the incidence of" exact="cervical cancer" post="by 24% and anal cancers in males and females"/>
  <result pre="boys with the 9-valent vaccine reduced the incidence of cervical" exact="cancer" post="by 24% and anal cancers in males and females"/>
  <result pre="as HPV-18 E7 and detoxified adenylate cyclase (CyaA) of Bordetella" exact="pertussis" post="binding to specific CD11b+ antigen presenting cells (APC) ("/>
  <result pre="the incidences of infection due to HPV along with the" exact="cancer" post="related to the virus. Moreover, a herd immunity is"/>
  <result pre="asthmatic attack in a 10-year-old boy who had experienced seasonal" exact="allergy" post="and bronchial asthma; high fever (&amp;gt;38°C), body pain, headache,"/>
  <result pre="thrombocytopenia, SLE, vasculitis, alopecia, CNS demyelinating conditions, ovarian damage, or" exact="irritable bowel syndrome" post="were significantly more likely than control to have received"/>
  <result pre="study demonstrated the therapeutic potential of curcumin in high-risk HPV-infected" exact="oral cancer" post="cells. Curcumin down-regulated HPV transcription by suppressing the cellular"/>
  <result pre="demonstrated the therapeutic potential of curcumin in high-risk HPV-infected oral" exact="cancer" post="cells. Curcumin down-regulated HPV transcription by suppressing the cellular"/>
  <result pre="selectively inhibited E6 oncogene-mediated p53 degradation during carcinogenesis in HPV-16-positive" exact="oral cancer" post="cells ( 245– 248). Another study showed that certain"/>
  <result pre="inhibited E6 oncogene-mediated p53 degradation during carcinogenesis in HPV-16-positive oral" exact="cancer" post="cells ( 245– 248). Another study showed that certain"/>
  <result pre="properly planned randomized trial has been introduced in patients with" exact="cervical cancer" post="that shows metastasis to compare solely chemotherapy versus chemotherapy"/>
  <result pre="planned randomized trial has been introduced in patients with cervical" exact="cancer" post="that shows metastasis to compare solely chemotherapy versus chemotherapy"/>
  <result pre="are specific to HPV can be obtained with consistency from" exact="cervical cancer" post="patients. By the significance of local microenvironment of HPV-induced"/>
  <result pre="specific to HPV can be obtained with consistency from cervical" exact="cancer" post="patients. By the significance of local microenvironment of HPV-induced"/>
  <result pre="prove to be efficacious. Ultimately, the main goal is a" exact="suppression" post="of regulatory T cells and a generation of an"/>
  <result pre="photosensitizer dye IR700 coupled with HPV VLPs, when exposed to" exact="cervical cancer" post="cell lines and 690-nm light causes necrosis-like cell death"/>
  <result pre="dye IR700 coupled with HPV VLPs, when exposed to cervical" exact="cancer" post="cell lines and 690-nm light causes necrosis-like cell death"/>
  <result pre="(traditional) which are used for preventing as well as treating" exact="cancer" post="in relation to HPV. The inhibitory effect of Chai"/>
  <result pre="the protein level as well as mRNA of p53 in" exact="cancer" post="cells of the cervix. The antitumor effect of the"/>
  <result pre="well-tolerated in humans ( 304). RNA interference (RNAi)-based therapies For" exact="cancer" post="therapies based on RNAi, an ideal model system is"/>
  <result pre="TP53 expression. Subsequently, apoptosis is induced in cell lines of" exact="cervical cancer" post="origin which are positive for HPV-16 ( 307– 309)."/>
  <result pre="expression. Subsequently, apoptosis is induced in cell lines of cervical" exact="cancer" post="origin which are positive for HPV-16 ( 307– 309)."/>
  <result pre="and intratumoral administration of these siRNAs resulted in induction of" exact="cervical cancer" post="cell apoptosis. In mice (immunocompetent), there is development of"/>
  <result pre="intratumoral administration of these siRNAs resulted in induction of cervical" exact="cancer" post="cell apoptosis. In mice (immunocompetent), there is development of"/>
  <result pre="murine origin ( 311). In Caski cells, there may be" exact="suppression" post="of tumors if siRNAs are injected intratumorally ( 312)."/>
  <result pre="of p53 pathway ( 305). Localized immunomodulation For clearance or" exact="suppression" post="of infection due to HPV immunologically in a normal"/>
  <result pre="Immunotherapy Immunotherapy has emerged as an adjunctive treatment for standard" exact="cancer" post="treatments (surgery, radiotherapy and/or chemotherapy). Substances used in the"/>
  <result pre="cancer treatments (surgery, radiotherapy and/or chemotherapy). Substances used in the" exact="cancer" post="immunotherapy include non-specific immune stimulators, cytokines, monoclonal antibodies and"/>
  <result pre="months reduces the otherwise high recurence and progression rates of" exact="bladder cancer" post="by causing stimulation of effective immune response against cancer"/>
  <result pre="reduces the otherwise high recurence and progression rates of bladder" exact="cancer" post="by causing stimulation of effective immune response against cancer"/>
  <result pre="bladder cancer by causing stimulation of effective immune response against" exact="cancer" post="cells (American Cancer Society). Cytokines (such as interferons) enhance"/>
  <result pre="conjugated (loaded) with radioisotope, toxin, or drug, kill directly the" exact="cancer" post="cells. Some antibodies recognizes molecule which is highly expressed"/>
  <result pre="cells. Some antibodies recognizes molecule which is highly expressed on" exact="cancer" post="cells such that the cells are better seen by"/>
  <result pre="can also cause inhibition of downstream cell signaling and prevent" exact="cancer" post="cell shading of decoy to increase effectiveness of the"/>
  <result pre="the form of bispecific T cell engager (BITE) bind to" exact="cancer" post="cell and effector T cell simultaneously and bring them"/>
  <result pre="activity which is suppressed by ligands highly expressed on the" exact="cancer" post="cells leading consequently to not only cancer cell death,"/>
  <result pre="expressed on the cancer cells leading consequently to not only" exact="cancer" post="cell death, but also death of regulatory T cells"/>
  <result pre="adoptive/autologous tumor infiltrating lymphocytes ( 321) are effective in several" exact="cancer" post="immunotherapy. These options canbe adopted for treatment of HPV-mediated"/>
  <result pre="16/18 E6 (C1P5; Abcam) administered repeatedly induced apoptosis of HPV-related" exact="cervical cancer" post="( 323). Miscellaneous therapies Cimetidine has been found to"/>
  <result pre="E6 (C1P5; Abcam) administered repeatedly induced apoptosis of HPV-related cervical" exact="cancer" post="( 323). Miscellaneous therapies Cimetidine has been found to"/>
  <result pre="by inhibition of T suppressor cell function and enhances delayed-type" exact="hypersensitivity" post="(DTH) ( 324). One interesting immunomodulator is dinitrochlorobenzene (DNCB)"/>
  <result pre="HPV infections, including warts, vulvar cancer, penile neoplasms, anal carcinoma," exact="prostate cancer," post="bladder cancer, cervical cancer, rectal cancer, oral cancer and"/>
  <result pre="including warts, vulvar cancer, penile neoplasms, anal carcinoma, prostate cancer," exact="bladder cancer," post="cervical cancer, rectal cancer, oral cancer and tonsil cancer"/>
  <result pre="vulvar cancer, penile neoplasms, anal carcinoma, prostate cancer, bladder cancer," exact="cervical cancer," post="rectal cancer, oral cancer and tonsil cancer September 28,"/>
  <result pre="anal carcinoma, prostate cancer, bladder cancer, cervical cancer, rectal cancer," exact="oral cancer" post="and tonsil cancer September 28, 2016 Application ( 336)"/>
  <result pre="carcinoma, prostate cancer, bladder cancer, cervical cancer, rectal cancer, oral" exact="cancer" post="and tonsil cancer September 28, 2016 Application ( 336)"/>
  <result pre="cancer, bladder cancer, cervical cancer, rectal cancer, oral cancer and" exact="tonsil cancer" post="September 28, 2016 Application ( 336) 12. Multitype HPV"/>
  <result pre="bladder cancer, cervical cancer, rectal cancer, oral cancer and tonsil" exact="cancer" post="September 28, 2016 Application ( 336) 12. Multitype HPV"/>
  <result pre="membranes November 21, 2013 Application ( 341) 17. Treatment of" exact="cancer" post="and benign proliferative disorders WO 2015059485 A1 Hampson I,"/>
  <result pre="V, Cantarella G, Scuderi F, Billeter M, Fazzio A Recombinant" exact="measles" post="virus vectors containing heterologous nucleic acid encoding for one"/>
  <result pre="*** ( 362) Arsenic trioxide – Cell culture HPVpositive HeLa" exact="cancer" post="cell line ( 363) HeLa cells (HPV18 positive) ("/>
  <result pre="52, and 6 ( 288) 1 (Human immunodeficiency virus and" exact="hepatitis" post="C virus positive) – – ( 370) Cidofovir 12"/>
  <result pre="the history of prevention of cancer. The incidence of HPV-induced" exact="cervical cancer" post="will reduce drastically if adolescent girls are immunized, and"/>
  <result pre="history of prevention of cancer. The incidence of HPV-induced cervical" exact="cancer" post="will reduce drastically if adolescent girls are immunized, and"/>
  <result pre="of the Western world, the screening to detect cervical HPV-induced" exact="cancer" post="is not performed on a regular basis. In this"/>
  <result pre="Laskar N Joly SN Human Papilloma virus vaccine: future of" exact="cervical cancer" post="prevention. J Enam Med Coll. ( 2016) 6: 157–"/>
  <result pre="N Joly SN Human Papilloma virus vaccine: future of cervical" exact="cancer" post="prevention. J Enam Med Coll. ( 2016) 6: 157–"/>
  <result pre="and priorities for research on prevention of HPV infection and" exact="cervical cancer" post=". Vaccine ( 2006) 24: 242– 9. 10.1016/j.vaccine.2006.06.038 16950013"/>
  <result pre="priorities for research on prevention of HPV infection and cervical" exact="cancer" post=". Vaccine ( 2006) 24: 242– 9. 10.1016/j.vaccine.2006.06.038 16950013"/>
  <result pre="2007) 56, 1– 24. 17380109 24. Kaarthigeyan K . Cervical" exact="cancer" post="in India and HPV vaccination. Ind J Med Paediatr"/>
  <result pre="e2– e5. 10.3928/19382359-20161216-01 28079910 30. Frazer IH . Prevention of" exact="cervical cancer" post="through papillomavirus vaccination. Nat Rev Immunol. ( 2004) 4:"/>
  <result pre="e5. 10.3928/19382359-20161216-01 28079910 30. Frazer IH . Prevention of cervical" exact="cancer" post="through papillomavirus vaccination. Nat Rev Immunol. ( 2004) 4:"/>
  <result pre="IH . HPV vaccines: the beginning of the end for" exact="cervical cancer." post="Curr Opinion Immunol. ( 2007) 19: 232– 8. 10.1016/j.coi.2007.01.004"/>
  <result pre="al. . Epidemiologic classification of human papillomavirus types associated with" exact="cervical cancer" post=". N Engl J Med. ( 2003) 348: 518–"/>
  <result pre=". Epidemiologic classification of human papillomavirus types associated with cervical" exact="cancer" post=". N Engl J Med. ( 2003) 348: 518–"/>
  <result pre="papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive" exact="cervical cancer" post="in Europe . Int J Cancer ( 2013) 132:"/>
  <result pre="type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical" exact="cancer" post="in Europe . Int J Cancer ( 2013) 132:"/>
  <result pre="4 and 9-valent HPV vaccines on morbidity and mortality from" exact="cervical cancer" post=". Hum Vaccin Immunother. ( 2016) 12: 1332– 42."/>
  <result pre="and 9-valent HPV vaccines on morbidity and mortality from cervical" exact="cancer" post=". Hum Vaccin Immunother. ( 2016) 12: 1332– 42."/>
  <result pre=". Human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine for the prevention of" exact="cervical cancer" post="and HPV-related diseases . Expert Rev Vaccines ( 2016)"/>
  <result pre="Human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine for the prevention of cervical" exact="cancer" post="and HPV-related diseases . Expert Rev Vaccines ( 2016)"/>
  <result pre="AL Vroling H et al. . Risk of new onset" exact="autoimmune disease" post="in 9- to 25-year-old women exposed to human papillomavirus-16/18"/>
  <result pre="Kim JJ Burger EA Sy S Campos NG . Optimal" exact="cervical cancer" post="screening in women vaccinated against human papillomavirus. J Natl"/>
  <result pre="JJ Burger EA Sy S Campos NG . Optimal cervical" exact="cancer" post="screening in women vaccinated against human papillomavirus. J Natl"/>
  <result pre="S Chattopadhyay A Samanta L Panigrahi P . HPV and" exact="cervical cancer" post="epidemiology- Current status of HPV vaccination in India. Asian"/>
  <result pre="Chattopadhyay A Samanta L Panigrahi P . HPV and cervical" exact="cancer" post="epidemiology- Current status of HPV vaccination in India. Asian"/>
  <result pre="L1 binding protein of human papillomavirus, an etiological agent of" exact="cervical cancer," post="using bioinformatics tools . Int J Pharm Sci Res."/>
  <result pre="( 2011). Direct identification of an HPV-16 tumor antigen from" exact="cervical cancer" post="biopsy specimens. Front Immunol. 13: 75 10.3389/fimmu.2011.00075 86. Baidya"/>
  <result pre="2011). Direct identification of an HPV-16 tumor antigen from cervical" exact="cancer" post="biopsy specimens. Front Immunol. 13: 75 10.3389/fimmu.2011.00075 86. Baidya"/>
  <result pre="Hangartner L Caballero M Pavlovic J et al. . Attenuated" exact="measles" post="virus as a vaccine vector. Vaccine ( 2007) 25:"/>
  <result pre="Schiller JT Billeter M Naim HY et al. . Recombinant" exact="measles" post="virus-HPV vaccine candidates for prevention of cervical carcinoma. Vaccine"/>
  <result pre="NM et al. Human tumor growth is inhibited by a" exact="vaccinia virus" post="carrying the E2 gene of bovine papillomavirus . Cancer"/>
  <result pre="et al. . Safety and immunogenicity of TA-HPV, a recombinant" exact="vaccinia virus" post="expressing modified human papillomavirus (HPV)-16 and HPV-18 E6 and"/>
  <result pre="and HPV-18 E6 and E7 genes, in women with progressive" exact="cervical cancer" post=". Clin Cancer Res. ( 2002) 8: 3676– 85."/>
  <result pre="HPV-18 E6 and E7 genes, in women with progressive cervical" exact="cancer" post=". Clin Cancer Res. ( 2002) 8: 3676– 85."/>
  <result pre="VV Rosas GA Merchant H Rosales R . A recombinant" exact="vaccinia virus" post="containing the papilloma E2 protein promotes tumor regression by"/>
  <result pre="JJ Verhelst R Rees H . HPV vaccines to prevent" exact="cervical cancer" post="and genital warts: an update. Vaccine ( 2014) 32:"/>
  <result pre="Verhelst R Rees H . HPV vaccines to prevent cervical" exact="cancer" post="and genital warts: an update. Vaccine ( 2014) 32:"/>
  <result pre="DM Demars LR . Primary strategies for HPV infection and" exact="cervical cancer" post="prevention. Clin Obstet Gynecol. ( 2014) 57: 256– 78."/>
  <result pre="Demars LR . Primary strategies for HPV infection and cervical" exact="cancer" post="prevention. Clin Obstet Gynecol. ( 2014) 57: 256– 78."/>
  <result pre="papillomavirus type 16 L1 as a potential live vaccine against" exact="cervical cancer" post="and typhoid fever . Clin Vaccine Immunol. ( 2007)"/>
  <result pre="type 16 L1 as a potential live vaccine against cervical" exact="cancer" post="and typhoid fever . Clin Vaccine Immunol. ( 2007)"/>
  <result pre="L1 as a potential live vaccine against cervical cancer and" exact="typhoid fever" post=". Clin Vaccine Immunol. ( 2007) 14: 1285– 95."/>
  <result pre="of its protective efficacy and immunogenicity in the guinea pig" exact="keratoconjunctivitis" post="model . Acta Biochim Biophys Sin. ( 2009) 41:"/>
  <result pre="in order to produce more effective therapeutic DNA vaccines in" exact="cervical cancer" post="model . Iran J Cancer Prev. ( 2015) 8:"/>
  <result pre="order to produce more effective therapeutic DNA vaccines in cervical" exact="cancer" post="model . Iran J Cancer Prev. ( 2015) 8:"/>
  <result pre="Galon J et al. . Trial watch: DNA vaccines for" exact="cancer" post="therapy. Oncoimmunology ( 2013) 2: e23803. 10.4161/onci.23803 23734328 165."/>
  <result pre="in design of immunogenic and effective naked DNA vaccines against" exact="cancer" post=". Recent Pat. Anticancer Drug Discov. ( 2014) 9:"/>
  <result pre="Fridman W et al. . Trial watch: DNA vaccines for" exact="cancer" post="therapy. Oncoimmunology ( 2014) 3: e28185. 10.4161/onci.28185 24800178 167."/>
  <result pre="DG . Preclinical and clinical development of DNA vaccines for" exact="prostate cancer." post="Urol Oncol. ( 2016) 34: 193– 204. 10.1016/j.urolonc.2013.09.014 24332642"/>
  <result pre="capable of eliciting specific immune response in patients with advanced" exact="cervical cancer" post=". J Transl Med. ( 2014) 12: 353. 10.1186/s12967-014-0353-4"/>
  <result pre="of eliciting specific immune response in patients with advanced cervical" exact="cancer" post=". J Transl Med. ( 2014) 12: 353. 10.1186/s12967-014-0353-4"/>
  <result pre="18 E7-pulsed dendritic cell vaccination of stage IB or IIA" exact="cervical cancer" post="patients: a phase I escalating-dose trial . J Virol."/>
  <result pre="E7-pulsed dendritic cell vaccination of stage IB or IIA cervical" exact="cancer" post="patients: a phase I escalating-dose trial . J Virol."/>
  <result pre="187. Monk BJ Tewari KS . Evidence-based therapy for recurrent" exact="cervical cancer." post="J Clin Oncol. ( 2014) 32: 2687– 90. 10.1200/JCO.2014.56.8733"/>
  <result pre="the impact of cervarix vaccination on human papillomavirus infection and" exact="cervical cancer" post="in the United Kingdom . Hum Vaccin Immunother. ("/>
  <result pre="impact of cervarix vaccination on human papillomavirus infection and cervical" exact="cancer" post="in the United Kingdom . Hum Vaccin Immunother. ("/>
  <result pre="Cervarix™: a vaccine for the prevention of HPV 16, 18-associated" exact="cervical cancer." post="Biol Targets Ther. ( 2008) 2: 107– 13. 198."/>
  <result pre="impact of Cervarix™ vaccination on oncogenic human papillomavirus infection and" exact="cervical cancer" post="in the United Kingdom . Hum Vaccin Immunother. ("/>
  <result pre="of Cervarix™ vaccination on oncogenic human papillomavirus infection and cervical" exact="cancer" post="in the United Kingdom . Hum Vaccin Immunother. ("/>
  <result pre=". Eradication of established tumors by vaccination with recombinant Bordetella" exact="pertussis" post="adenylate cyclase carrying the human papillomavirus 16 E7 oncoprotein"/>
  <result pre="Kowa H Kanda F Toda T . Two cases of" exact="acute disseminated encephalomyelitis" post="following vaccination against human papilloma virus . Intern Med."/>
  <result pre="Kanda F Toda T . Two cases of acute disseminated" exact="encephalomyelitis" post="following vaccination against human papilloma virus . Intern Med."/>
  <result pre="Kim JS Shin DI Lee SS et al. . Recurrent" exact="optic neuritis" post="and neuromyelitis optica-IgG following first and second human papillomavirus"/>
  <result pre="Curcumin modulates cellular AP-1, NF-κB, and HPV16 E6 proteins in" exact="oral cancer." post="Ecancermedicalscience ( 2015) 9: 525 10.3332/ecancer.2015.525 25932049 249. Banister"/>
  <result pre="et al. . Cycloxygenase-2 inhibition augments the efficacy of a" exact="cancer" post="vaccine. Clin Cancer Res. ( 2006) 12: 214– 22."/>
  <result pre="267. Wright TC Jr Kuhn L . Alternative approaches to" exact="cervical cancer" post="screening for developing countries. Best Pract Res Clin Obstet"/>
  <result pre="Wright TC Jr Kuhn L . Alternative approaches to cervical" exact="cancer" post="screening for developing countries. Best Pract Res Clin Obstet"/>
  <result pre="imiquimod 5% cream for persistent human papillomavirus in genital intraepithelial" exact="neoplasm" post=". Taiwan J Obstet Gynecol. ( 2013) 52: 475–"/>
  <result pre="isolated from marine fungus Aspergillus sp. induces apoptosis of human" exact="cervical cancer" post="and chondrosarcoma cells . Mar Drugs ( 2013) 12:"/>
  <result pre="from marine fungus Aspergillus sp. induces apoptosis of human cervical" exact="cancer" post="and chondrosarcoma cells . Mar Drugs ( 2013) 12:"/>
  <result pre="interferon alfa-2b in the treatment of advanced stage or recurrent" exact="cervical cancer" post=". Int J Gynecol Cancer. ( 2014) 24: 1636–"/>
  <result pre="alfa-2b in the treatment of advanced stage or recurrent cervical" exact="cancer" post=". Int J Gynecol Cancer. ( 2014) 24: 1636–"/>
  <result pre="with interferon alpha and ribavirin in a patient with acquired" exact="aplastic anemia" post=". Int J Infect Dis. ( 2014) 23: 25–"/>
  <result pre="interferon alpha and ribavirin in a patient with acquired aplastic" exact="anemia" post=". Int J Infect Dis. ( 2014) 23: 25–"/>
  <result pre="290. Guo-Qin H Clinical observation of paiteling on treatment of" exact="cervicitis" post="combined with high-risk HPV infection . Chin J Woman"/>
  <result pre="XS Guan HS Wang W . Potential anti-HPV and related" exact="cancer" post="agents from marine resources: an overview. Mar Drugs ("/>
  <result pre="extract fraction on expressions of HPVE6 and P53 genes in" exact="cervical cancer" post="cell lines . China J Tradit Chin Med Pharm."/>
  <result pre="fraction on expressions of HPVE6 and P53 genes in cervical" exact="cancer" post="cell lines . China J Tradit Chin Med Pharm."/>
  <result pre="et al. RNA interference against human papilloma virus oncogenes in" exact="cervical cancer" post="cells results in increased sensitivity to cisplastin . Mol"/>
  <result pre="al. RNA interference against human papilloma virus oncogenes in cervical" exact="cancer" post="cells results in increased sensitivity to cisplastin . Mol"/>
  <result pre="against HPV16 E7 oncogene leads to viral E6 and E7" exact="suppression" post="in cervical cancer cells and apoptosis via upregulation of"/>
  <result pre="E7 oncogene leads to viral E6 and E7 suppression in" exact="cervical cancer" post="cells and apoptosis via upregulation of Rb and p53"/>
  <result pre="oncogene leads to viral E6 and E7 suppression in cervical" exact="cancer" post="cells and apoptosis via upregulation of Rb and p53"/>
  <result pre="specific E6 and E7 siRNAs for treatment of HPV16 positive" exact="cervical cancer" post=". Cancer Gene Ther. ( 2008) 15: 140– 153."/>
  <result pre="E6 and E7 siRNAs for treatment of HPV16 positive cervical" exact="cancer" post=". Cancer Gene Ther. ( 2008) 15: 140– 153."/>
  <result pre=". Human papillomavirus: current and future RNAi therapeutic strategies for" exact="cervical cancer" post=". J Clin Med. ( 2015) 4: 1126– 55."/>
  <result pre="Human papillomavirus: current and future RNAi therapeutic strategies for cervical" exact="cancer" post=". J Clin Med. ( 2015) 4: 1126– 55."/>
  <result pre="synergistically protects against tumor growth in a murine model of" exact="ovarian cancer" post=". PLoS ONE ( 2014) 9: e89350. 10.1371/journal.pone.0089350 320."/>
  <result pre="protects against tumor growth in a murine model of ovarian" exact="cancer" post=". PLoS ONE ( 2014) 9: e89350. 10.1371/journal.pone.0089350 320."/>
  <result pre="F Cao J Neelalpu SS . Versatile CAR T-cells for" exact="cancer" post="immunotherapy. Contemp Oncol (Pozn) ( 2018) 22: 73– 80."/>
  <result pre="adoptive cell therapy with tumor infiltrating lymphocytes for non-small cell" exact="lung cancer" post="patients . Cancer Immunol Immunother. ( 2018) 67: 1221–"/>
  <result pre="cell therapy with tumor infiltrating lymphocytes for non-small cell lung" exact="cancer" post="patients . Cancer Immunol Immunother. ( 2018) 67: 1221–"/>
  <result pre="demonstrates theraprutic effects via induction of apoptosis in HPV related" exact="cervical cancer" post=". J Immunol. ( 2016) 196: 214– 9. 324."/>
  <result pre="theraprutic effects via induction of apoptosis in HPV related cervical" exact="cancer" post=". J Immunol. ( 2016) 196: 214– 9. 324."/>
  <result pre="A1 ( 2013). 342. Hampson I Hampson L Treatment of" exact="cancer" post="and benign proliferative disorders. WO 2015059485 A1 ( 2015)."/>
  <result pre="Wen X . Effective delivery of arsenic trioxide to HPV-positive" exact="cervical cancer" post="cells using optimised liposomes: a size and charge study"/>
  <result pre="X . Effective delivery of arsenic trioxide to HPV-positive cervical" exact="cancer" post="cells using optimised liposomes: a size and charge study"/>
  <result pre="E Ruotsalainen P Helenius H Hietanen S . Chemoradiation of" exact="cervical cancer" post="cells: targeting human papillomavirus E6 and p53 leads to"/>
  <result pre="Ruotsalainen P Helenius H Hietanen S . Chemoradiation of cervical" exact="cancer" post="cells: targeting human papillomavirus E6 and p53 leads to"/>
  <result pre="2003). Treatment of human papillomavirus (HPV) type 16-infected cells using" exact="herpes simplex" post="virus type 1 thymidine kinase-mediated gene therapy transcriptionally regulated"/>
  <result pre="HPV 18 oncoproteins With RNA interference causes growth inhibition of" exact="cervical cancer" post="cells . Reprod Sci. ( 2007) 14: 20– 8."/>
  <result pre="18 oncoproteins With RNA interference causes growth inhibition of cervical" exact="cancer" post="cells . Reprod Sci. ( 2007) 14: 20– 8."/>
  <result pre=". Induction of apoptosis by chitosan/HPV16 E7 siRNA complexes in" exact="cervical cancer" post="cells. Mol Med Rep. ( 2013) 7: 998– 1002."/>
  <result pre="Induction of apoptosis by chitosan/HPV16 E7 siRNA complexes in cervical" exact="cancer" post="cells. Mol Med Rep. ( 2013) 7: 998– 1002."/>
 </snippets>
</snippetsTree>
